Understanding adaptive responses to therapy
Chairs: Prof Lisa Horvath, A/Prof Lisa Butler
Back to listHypoxia and Radioresistance: Understanding Therapeutic Response
- Time:
- 10:30 AM - 10:50 AM
- Speakers:
Dr Paul Boutros
Molecular markers of response to neoadjuvant chemotherapy for muscle invasive bladder cancer
- Time:
- 10:50 AM - 11:10 AM
- Speakers:
Dr Peter Black
The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer
- Time:
- 11:10 AM - 11:30 AM
- Speakers:
Dr Luc Furic
Androgen receptor interactomics identifies GRHL2 as an important new player in prostate cancer progression
- Time:
- 11:30 AM - 11:50 AM
- Speakers:
Dr Luke Selth
Targeting the adpative plasticity response to androgen targeted therapies
- Time:
- 11:50 AM - 12:10 PM
- Speakers:
Dr Brett Hollier
Endocrine reprograming triggered by treatment with androgen targeted therapies
- Time:
- 12:10 PM - 12:30 PM
- Speakers:
Prof Colleen Nelson